NEW for SLAS2015: Innovation AveNEW participants will have access to individual consulting sessions with recognized expert entrepreneurs with deep experience in the scientific technology industry. This select group includes Scott Atkin of SAGIAN Ventures, Kevin Hrusovsky of Quanterix, and Rob Nail of Singularity University. This unique access to experts will undoubtedly provide key insight on commercial viability, market trends, potential business connections, and go-to market strategies to Innovation AveNEW participants. See more information here.
... for start-up companies.
Kicking off the calendar year, SLAS2015 is the platform event for established companies launching new products and services. Innovation AveNEW is an in-kind, cost-sensitive program affording emerging, start-up companies the opportunity to actively engage and participate in a world-class event which helps to grow and scale their business as well as directly connects them with purchasing influencers and decision-makers from more than 40 countries.
The mission for Innovation AveNEW is simple — to offer start-up, entrepreneurial companies in the area of laboratory science and technology a venue for positive, collaborative interaction and exposure for their product and/or service concept. Innovation AveNEW will be located in a specially designated area on the exhibit floor.
Only a select few start-up companies are chosen for this program each year. Those chosen can only be selected for participation one time. The products and/or services offered must be available for sale/distribution in the year 2015.
SLAS Innovation AveNEW at SLAS2015 will feature the following eight companies from four different countries:
Be sure to stop by Innovation AveNEW in the SLAS2015 Exhibition to visit with these companies and see the technology which earned this important distinction.
SLAS thanks all companies that submitted applications to participate in Innovation AveNEW at SLAS2015.
The following scientific technology entrepreneurial experts will provide complimentary consulting to Innovation AveNEW participants at SLAS2015:
Scott Atkin is an accomplished business executive with extensive experience in all functions of business operations. He started his career at a Fortune 100 company as a research scientist. He left the corporate world to found a laboratory automation startup which was subsequently sold to Beckman Instruments. From there he spent over 15 years at Beckman Coulter as an executive officer with responsibility for a portfolio of global businesses representing nearly $2BB in revenue. In addition, Scott had direct responsibility for the engineering development organization supporting all product lines within the company. Scott is now working in an advisory role for middle market private equity as well as working with emerging entrepreneurs through his role on the Board of Advisors for an angel investing group, Vision-Tech Partners. In addition, he recently helped co-found two new businesses associated with innovation and entrepreneurship. Throughout his career Scott has helped create and grow businesses through innovation, entrepreneurship and M&A activity and has extensive experience with the operation of private and public companies of all sizes.
Kevin Hrusovsky brings 20+ years of experience in life science and diagnostics industries to SLAS2015. Prior to his current role at Quanterix, he was President of PerkinElmer Life Sciences & Technology; CEO of Caliper Life Sciences (sold to PerkinElmer); and CEO of Zymark Corporation (sold to Caliper). Earlier, Kevin was President of FMC Corporation’s Pharmaceuticals and International Agricultural Products. Prior to that, Kevin held numerous management positions at DuPont. Kevin currently serves on the Board of Directors of 908 Devices, SynapDx, the Educational Board of the Massachusetts Biotech Council, the Advisory Committee for the Center for Biomedical Engineering at Brown University, the Association for Laboratory Automation, the JALA Editorial Board, and the Strategy Committee of Children’s Hospital Boston. He formerly served on the boards of SeraCare, Caliper Life Sciences, Xenogen – XGEN and Alliant Medical Technology. Kevin received his B.S. in Mechanical Engineering from Ohio State University and an M.B.A. from Ohio University. He was awarded the 2013 Entrepreneur of the Year from Ohio State University and received an Honorary Doctorate degree from Framingham State University for contributions in life sciences and personal medicine.
Rob Nail is the CEO and Associate founder of Singularity University. At Singularity, Rob brings a unique entrepreneurial and impact-focused approach to growing a non-traditional university as a model for the future and a forum to catalyze a global ecosystem that leverages exponential technologies to help solve humanity’s grand challenges. Prior to Singularity, Rob co-founded Velocity11 in 1999, building automation equipment and robotics for cancer research and drug discovery. After Velocity 11 was acquired by Agilent Technologies in 2007, Rob found his true calling and biggest challenge yet with Singularity University. Rob is also a co-founder of Alite Designs, is an active angel investor and advisor, and holds degrees in Mechanical, Materials Science and Manufacturing Engineering with a focus on design and robotics from UC Davis and Stanford University.
Mary Geismann, Manager, Member Services
630.256.7527, ext. 109
All information is confidential and will only be shared among the Review Panel and SLAS Directors and Staff. See terms and conditions information.
Submission Deadline: Friday, October 10, 2014